Company intelligence
MycoStories
Supporting the founders, investors, and industry leaders building with fungi biotechnology
About MycoStories
MycoStories is the leading intelligence platform and industry network for fungi biotechnology, connecting startups, investors, corporates, and researchers building across food, materials, health, and agriculture. We work with: 🚀 Founders & Startups: investor introductions, commercial partnerships, and business, technical, and scientific expertise to scale. 🏢 Corporates: innovation scouting, supplier identification, and strategic partnership development 📈 Investors: in-depth market research, deal flow, and technical due diligence. 🔬 Researchers & Institutions: industry connections and pathways from lab to commercial application. Our weekly insights newsletter reaches 100,000 subscribers across four continents, with content reaching over 1M people monthly. We track 1,000+ organisations globally, work with 100+ expert consultants, and have delivered 50+ projects for clients including Decathlon, Lesaffre, and more.
Verified activity
Signals from MycoStories
7 published signals
Research & Knowledge
MycoStories published a new study in PLOS Biology revealing that Arctic fjord fungi sequester dissolved organic matter into their biomass rather than releasing it as CO₂.
Reported by Marc Violo
Research & Knowledge
MycoStories highlights that researchers at the University of the Witwatersrand are leveraging C1, a modified fungal platform developed for industrial enzymes, to produce vaccines through conventional microbial fermentation.
Reported by MycoStories
Capital & Finance
MycoStories notes that the AVMA is backing the vision of producing a Rift Valley fever vaccine and an HPV vaccine targeting subtype 35 with up to $1.2 billion over ten years.
Reported by MycoStories
Partnerships
MycoStories announced a partnership between Ginkgo Bioworks and ACIES Bio Ltd. to engineer Aspergillus niger strains for economic competition at scale.
Reported by Marc Violo
Research & Knowledge
MycoStories highlights that researchers at the University of the Witwatersrand are leveraging C1, a modified fungal platform developed for industrial enzymes, to produce vaccines through conventional microbial fermentation.
Reported by Marc Violo
Presence & Recognition
MycoStories is hosting a Fungi for Climate event during Climate Week NYC, running alongside UN General Assembly week and the world's largest climate gathering.
Reported by MycoStories
Presence & Recognition
MycoStories is hosting a Fungi for Climate event during Climate Week NYC, running alongside UN General Assembly week and the world's largest climate gathering on Friday 25 September in Chelsea.
Reported by Marc Violo